SCHEMBL184796

SCHEMBL184796

O=C(Nc1ncc(Oc2ccc(F)cc2)s1)C(Oc1ccc(F)cc1F)c1ccc(S(=O)(=O)C2CC2)cc1

nearest known ligand 0.90

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL184990 0.95 GCK (1.00) GCK
SCHEMBL185981 0.94 GCK (0.87) GCK
SCHEMBL184388 0.93 GCK (0.86) GCK
SCHEMBL184944 0.93 GCK (1.00) GCK
SCHEMBL184834 0.92 GCK (0.88) GCK
SCHEMBL185148 0.91 GCK (0.87) GCK
SCHEMBL185169 0.91 GCK (1.00) GCK
SCHEMBL3768866 0.91 GCK (0.82) GCK
SCHEMBL184253 0.91 GCK (0.82) GCK
SCHEMBL184492 0.90 GCK (0.81) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP claimed
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP disclosed
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP disclosed